Glenorchy Capital’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
18,660
+743
+4% +$44.8K 0.04% 50
2026
Q1
$1.05M Buy
17,917
+2,536
+16% +$150K 0.06% 54
2025
Q4
$871K Sell
15,381
-1,253
-8% -$68.4K 0.05% 51
2025
Q3
$883K Sell
16,634
-538
-3% -$29.2K 0.13% 49
2025
Q2
$813K Sell
17,172
-88
-0.5% -$3.9K 0.12% 48
2025
Q1
$714K Sell
17,260
-180
-1% -$7.08K 0.44% 47
2024
Q4
$633K Sell
17,440
-313
-2% -$11.3K 0.37% 51
2024
Q3
$649K Buy
17,753
+1,260
+8% +$45K 0.2% 56
2024
Q2
$510K Buy
16,493
+2,575
+19% +$78.2K 0.16% 58
2024
Q1
$425K Buy
13,918
+4,445
+47% +$134K 0.15% 61
2023
Q4
$277K Buy
+9,473
New +$288K 0.11% 60

Other funds holding BTI

Glenorchy Capital's BTI Position: Q2 2026 in Review

Glenorchy Capital increased its British American Tobacco (BTI) stake by 4.1% in Q2 2026, buying an estimated $44.8K and bringing the position to 18,660 shares worth $1.15M. The position accounts for 0.04% of the portfolio, ranked #50.

Glenorchy Capital first reported a position in BTI in Q4 2023 and has held it in 11 quarters since. 909 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Glenorchy Capital held 18,660 shares of British American Tobacco worth $1.15M as of Q2 2026.
  • Glenorchy Capital bought 743 British American Tobacco shares in Q2 2026, an estimated $44.8K.
  • British American Tobacco made up 0.04% of Glenorchy Capital's portfolio in Q2 2026, its #50 holding.
  • Glenorchy Capital first reported a position in British American Tobacco in Q4 2023 and has held it in 11 quarters since.
  • 909 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Glenorchy Capital's 13F filing for Q2 2026, filed 29 Jul 2026.